It will be operational by mid-2026.

Sanofi inaugurated its $800m healthcare manufacturing facility, Modulus, located in Tuas Biomedical Park to be operational in mid-2026.

Modulus leverages an 'industry-first' modular concept that enables flexible manufacturing capabilities to produce next-generation vaccines and biological medicines.

It can be adapted to manufacture up to four vaccines or biopharmaceuticals simultaneously and be reconfigured to change over between pre-established technological platforms.

The facility can also house 34 standardised production modules, each equipped with interconnected and modular equipment to configure production lines rapidly according to specific needs.

Moreover, the site will generate 200 new jobs in Singapore including bioprocess engineers, automation specialists, data analysts, quality control experts, and specialists in artificial intelligence, machine learning, and bioinformatics.

Furthermore, it will make use of green technology such as solar panels, green electricity, and recycled materials in its construction.